Literature DB >> 21859268

Current status of regenerative replacement of the airway.

Silvia Baiguera1, Barbara D'Innocenzo, Paolo Macchiarini.   

Abstract

Tracheal replacement has been attempted since the beginning of the last century, but always failed because of the difficulties in harvesting and revascularizing its microvascular network and the necessity for heavy immunosuppression. Regenerative medicine is an emerging interdisciplinary field of research and clinical applications focused on the repair, replacement or regeneration of cells, tissues or organs to restore impaired function. Among the different regenerative medicine approaches, the application of scaffolds or matrices to grow new tissues or organs from isolated cells, tissue or synthetic compounds is the basic principle in tissue engineering. By doing so, immunosuppression is avoided. In this article, we describe the strategies that could have relevant clinical applications and the translational research approaches used to clinically replace irreversible diseases of the trachea, and discuss how to make this stem cell-based technology available to everyone.

Mesh:

Year:  2011        PMID: 21859268     DOI: 10.1586/ers.11.42

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  2 in total

1.  Genipin cross-linked decellularized tracheal tubular matrix for tracheal tissue engineering applications.

Authors:  Fei Sun; Yuan Jiang; Yanfei Xu; Hongcan Shi; Siquan Zhang; Xingchen Liu; Shu Pan; Gang Ye; Weidong Zhang; Fangbiao Zhang; Chonghao Zhong
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

2.  Regeneration of Tracheal Tissue in Partial Defects Using Porcine Small Intestinal Submucosa.

Authors:  Nelson Bergonse Neto; Lianna Ferrari Jorge; Julio C Francisco; Bruna Olandoski Erbano; Barbara Evelin Gonçalves Barboza; Larissa Luvison Gomes da Silva; Marcia Olandoski; Katherine Athayde Teixeira de Carvalho; Luiz Felipe Pinho Moreira; Jose Rocha Faria Neto; Eltyeb Abdelwahid; Luiz Cesar Guarita-Souza
Journal:  Stem Cells Int       Date:  2018-02-26       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.